Familial hyperhomocysteinemia with early development of atherosclerosis;Rodzinna hiperhomocysteinemia przebiegaja̧ca z wczesna̧ miażdżyca̧ tȩtnic

Polskie Archiwum Medycyny Wewnetrznej

Volumn 96, Issue 4, 1996, Pages 354-358

  DomagalŁa, Teresa B ^a   Libura, Magdalena ^a   Gozdecka, Halina ^a   Krzanowskl, Marek ^a   Szczeklik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Atherosclerosis; Folic acid; Hyperhomocysteinemia; Vitamine B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; BLOOD; CASE REPORT; CHILD; FEMALE; GENETICS; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; PRESCHOOL CHILD;

ADULT; AGED; ARTERIOSCLEROSIS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; VITAMIN B 12;

EID: 0030256010     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Kong S.S., Wong P. W.K., Malinow M. R.: Hyperhomocysteinemia as risk factor for occlusive vascular disease. Ann. Rev. Nutr., 1992. 12, 279.
2. Selhub J., Jacques P.F., Wilson W.F., Rush D., Rosenberg I.H.: Vitamin Status and Intake as primary determinants of homocystememia in elderly population. JAMA, 1993, 22, 2693.
3. Naruszewicz M., Mirkiewicz E., Olszewski A., McCully K.S.: Thiolation of low density lipoproteins by homocysteine thiolactone causes increased aggregation and altered interaction with cultured macrophages Nutr. Metab. Cardiovasc., 1994, 4, 70.
4. Mansoor M.A., Svardal A.M., Ueland P.M.: Determination of the in vivo redox status of cysteine, cystemglycine, homocysteine and glutathione in human plasma. Annal. Biochem., 1992, 200, 218.
5. Kang S.S., Wong P W.K. Genetic and nongenetic factors for moderate hyperhomocysteinemia. Atherosclerosis, 1996, 119, 138.
6. Kang S.S., Wong P.W.K., Norusis M : Homocysteinemia due to folate deficiency. Metabolism, 1987, 36, 458.
7. Boushey C.B., Beresford S.A., Omenn G.S.. Motuhky A.G.: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA, 1995, 3, 1049.